Clinical Trial

Development of an Accessible Cognitive Behavioral Therapy Digital Therapeutic for Individuals With Long COVID

Withdrawn
View on ClinicalTrials.gov →
Why the trial stopped
This study does not meet the clinical trial definition under FDAAA 801 / NIH policy - participants aren't prospectively assigned to an intervention, and no biomedical or behavioral outcome is evaluated.
Summary
This study will evaluate Toivoa-004 as an experimental digital therapeutic for persons with Long COVID suffering from anxiety or depression. This study will evaluate the completion rates of the Toivoa-004 program and survey the user's experience upon completion. Changes in anxiety and depression scores will be monitored during the study.
Protocol Amendment History 3 changes
critical Withdrawn before enrolling 2026-07-30
critical Trial withdrawn: This study does not meet the clinical trial definition under FDAAA 801 / NIH policy - participants aren't prospectively... 2026-07-30
notable Enrollment reduced: 20 -> 0 participants 2026-07-30
Trial Details
NCT Number NCT07714889
Lead Sponsor Toivoa Inc
Collaborators: National Institute of Nursing Research (NINR)
Conditions Long Covid, Depression, Anxiety
Start Date 2026-07
Primary Completion 2026-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-07-29